1076465

Bromazepam

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): 7-Bromo-5-(2-pyridyl)-3H-1,4-benzodiaxepin-2(1H)-one
• Empirical Formula (Hill Notation): C₁₄H₁₀BrN₃O
• CAS Number: 1812-30-2
• Molecular Weight: 316.15
• MDL number: MFCD00057902
• UNSPSC Code: 41116107
• PubChem Substance ID: 329749131
• NACRES: NA.24

Properties

• grade: pharmaceutical primary standard
• API family: bromazepam
• manufacturer/tradename: USP
• drug control: regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: O=C(CN=C1C2=CC=CC=N2)NC3=C1C=C(Br)C=C3
• InChI: 1S/C14H10BrN3O/c15-9-4-5-11-10(7-9)14(17-8-13(19)18-11)12-3-1-2-6-16-12/h1-7H,8H2,(H,18,19)
• InChI key: VMIYHDSEFNYJSL-UHFFFAOYSA-N
• Gene Information: human ... GABRA2(2555)

Description

General description

Bromazepam belongs to the 1,4-benzodiazepine class of compounds. It is a type of psychotropic drug, which finds therapeutic applications as an anti-anxiety agent.

Application

Bromazepam may be used as a standard in the quantitative determination of bromazepam in biosamples like human plasma using high performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS-MS).

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Safety Information

• Pictograms: GHS07
• Signal Word: Warning
• Hazard Statements: H302,H315,H319,H335
• Precautionary Statements: P301 + P312 + P330 - P305 + P351 + P338
• Hazard Classifications: Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Target Organs: Respiratory system
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable